{
    "eid": "2-s2.0-85138041925",
    "title": "Discovery of JAK2/3 Inhibitors from Quinoxalinone-Containing Compounds",
    "cover-date": "2022-09-20",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Chemistry (all)",
            "@code": "1600",
            "@abbrev": "CHEM"
        },
        {
            "@_fa": "true",
            "$": "Chemical Engineering (all)",
            "@code": "1500",
            "@abbrev": "CENG"
        }
    ],
    "keywords": [],
    "authors": [
        "Kamonpan Sanachai",
        "Panupong Mahalapbutr",
        "Lueacha Tabtimmai",
        "Supaphorn Seetaha",
        "Tanakorn Kittikool",
        "Sirilata Yotphan",
        "Kiattawee Choowongkomon",
        "Thanyada Rungrotmongkol"
    ],
    "citedby-count": 2,
    "ref-count": 71,
    "ref-list": [
        "Janus kinases in immune cell signaling",
        "The JAK-STAT Pathway: Impact on Human Disease and Therapeutic Intervention",
        "Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway",
        "The Pleiotropic Effects of the GM-CSF Rheostat on Myeloid Cell Differentiation and Function: More Than a Numbers Game",
        "Janus kinase inhibitors for the treatment of myeloproliferative neoplasias and beyond",
        "Interleukin-2: Inception, impact, and implications",
        "The regulation of JAKs in cytokine signaling and its breakdown in disease",
        "Advances in the Discovery of Selective JAK Inhibitors",
        "JAK inhibitors for the treatment of myeloproliferative neoplasms and other disorders",
        "Tyrphostin AG-490 inhibits cytokine-mediated JAK3/STAT5a/b signal transduction and cellular proliferation of antigen-activated human T cells",
        "FDA-approved small-molecule kinase inhibitors",
        "Structural and Thermodynamic Characterization of the TYK2 and JAK3 Kinase Domains in Complex with CP-690550 and CMP-6",
        "JAK2 inhibitors",
        "Prevention of organ allograft rejection by a specific Janus kinase 3 inhibitor",
        "Anti-inflammatory activity and neutrophil reductions mediated by the JAK1/JAK3 inhibitor, CP-690,550, in rat adjuvant-induced arthritis",
        "Janus kinase (JAK) inhibitors in the treatment of inflammatory and neoplastic diseases",
        "Recent patents in the discovery of small molecule inhibitors of JAK3",
        "Discovery of novel selective Janus kinase 2 (JAK2) inhibitors bearing a 1H-pyrazolo[3,4-d]pyrimidin-4-amino scaffold",
        "Discovery of 1-amino-5H-pyrido[4,3-b]indol-4-carboxamide inhibitors of Janus kinase 2 (JAK2) for the treatment of myeloproliferative disorders",
        "Quinoxaline-Based Scaffolds Targeting Tyrosine Kinases and Their Potential Anticancer Activity",
        "Quinoxaline: An insight into the recent pharmacological advances",
        "Design of two new chemotypes for inhibiting the Janus kinase 2 by scaffold morphing",
        "Discovery of novel selective Janus kinase 2 (JAK2) inhibitors bearing a 1H-pyrazolo[3,4-d]pyrimidin-4-amino scaffold",
        "Sulfoximines as Rising Stars in Modern Drug Discovery? Current Status and Perspective on an Emerging Functional Group in Medicinal Chemistry",
        "Novel Pieces for the Emerging Picture of Sulfoximines in Drug Discovery: Synthesis and Evaluation of Sulfoximine Analogues of Marketed Drugs and Advanced Clinical Candidates",
        "Metal-free direct oxidative C-C bond coupling of pyrazolones and quinoxalinones",
        "Persulfate-promoted oxidative C-N bond coupling of quinoxalinones and NH-sulfoximines",
        "Iodine-Catalyzed Oxidative Cross-Dehydrogenative Coupling of Quinoxalinones and Indoles: Synthesis of 3-(Indol-2-yl)quinoxalin-2-one under Mild and Ambient Conditions",
        "Discovery and SAR of potent, orally available 2,8-diaryl-quinoxalines as a new class of JAK2 inhibitors",
        "Molecular insights into regulation of JAK2 in myeloproliferative neoplasms",
        "Synthesis and evaluation of the cytotoxic activity of novel ethyl 4-[4-(4-substitutedpiperidin-1-yl)]benzyl-phenylpyrrolo[1,2-a]quinoxaline-carboxy late derivatives in myeloid and lymphoid leukemia cell lines",
        "Synthesis and evaluation of the antiproliferative activity of novel isoindolo[2,1-a]quinoxaline and indolo[1,2-a]quinoxaline derivatives",
        "Synthesis, 3D-QSAR analysis and biological evaluation of quinoxaline 1,4-di-N-oxide derivatives as antituberculosis agents",
        "Potent and Selective Inhibition of Polycythemia by the Quinoxaline JAK2 Inhibitor NVP-BSK805",
        "JAK2/STAT5 Inhibition Circumvents Resistance to PI3K/mTOR Blockade: A Rationale for Cotargeting These Pathways in Metastatic Breast Cancer",
        "Caspase Functions in Cell Death and Disease",
        "Apoptosis Imaging: Beyond Annexin v",
        "Executioner caspase-3 and caspase-7 are functionally distinct proteases",
        "Stathmin 1 inhibition amplifies ruxolitinib-induced apoptosis in JAK2V617F cells",
        "IRS2 silencing increases apoptosis and potentiates the effects of ruxolitinib in JAK2(V617F)-positive myeloproliferative neoplasms",
        "Reversine exhibits antineoplastic activity in JAK2(V)(617)(F)-positive myeloproliferative neoplasms",
        "The Recent Medicinal Chemistry Development of Jak2 Tyrosine Kinase Small Molecule Inhibitors",
        "Halogen Atoms in the Modern Medicinal Chemistry: Hints for the Drug Design",
        "Insights into the Binding Recognition and Susceptibility of Tofacitinib toward Janus Kinases",
        "Novel 2,4-disubstituted quinazolines as cytotoxic agents and JAK2 inhibitors: Synthesis, in vitro evaluation and molecular dynamics studies",
        "Expression, purification, and characterization of the native intracellular domain of human epidermal growth factor receptors 1 and 2 in Escherichia coli",
        "Potential tripeptides against the tyrosine kinase domain of human epidermal growth factor receptor (HER) 2 through computational and kinase assay approaches",
        "Biological Evaluation and Molecular Dynamics Simulation of Chalcone Derivatives as Epidermal Growth Factor-Tyrosine Kinase Inhibitors",
        "In silico identification and in vitro validation of nogalamycin N-oxide (NSC116555) as a potent anticancer compound against non-small-cell lung cancer cells",
        "Rapid method for protein quantitation by Bradford assay after elimination of the interference of polysorbate 80",
        "Dissecting Specificity in the Janus Kinases: The Structures of JAK-Specific Inhibitors Complexed to the JAK1 and JAK2 Protein Tyrosine Kinase Domains",
        "SWISS-MODEL: Homology modelling of protein structures and complexes",
        "Graphical analysis of pH-dependent properties of proteins predicted using PROPKA",
        "ZINC - A free database of commercially available compounds for virtual screening",
        "A fast flexible docking method using an incremental construction algorithm",
        "Fast tools for calculation of atomic charges well suited for drug design",
        "UCSF chimera - A visualization system for exploratory research and analysis",
        "Routine Microsecond Molecular Dynamics Simulations with AMBER on GPUs. 1. Generalized Born",
        "Ff14SB: Improving the Accuracy of Protein Side Chain and Backbone Parameters from ff99SB",
        "Development and testing of a general amber force field",
        "In Silico Elucidation of Potent Inhibitors and Rational Drug Design against SARS-CoV-2 Papain-like Protease",
        "Binding Hotspot and Activation Mechanism of Maltitol and Lactitol toward the Human Sweet Taste Receptor",
        "Rosmarinic Acid as a Potent Influenza Neuraminidase Inhibitor: In Vitro and in Silico Study",
        "Computational study on peptidomimetic inhibitors against SARS-CoV-2 main protease",
        "Structural insight into the recognition of S-adenosyl-L-homocysteine and sinefungin in SARS-CoV-2 Nsp16/Nsp10 RNA cap 2\u2032-O-Methyltransferase",
        "The Effect of Long-Range Electrostatic Interactions in Simulations of Macromolecular Crystals - A Comparison of the Ewald and Truncated List Methods",
        "LINCS: A linear constraint solver for molecular simulations",
        "PTRAJ and CPPTRAJ: Software for Processing and Analysis of Molecular Dynamics Trajectory Data"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60103462",
            "affilname": "King Mongkut's University of Technology North Bangkok",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60103462",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Khon Kaen",
            "@id": "60026046",
            "affilname": "Faculty of Medicine, Khon Kaen University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60026046",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60021944",
            "affilname": "Kasetsart University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60021944",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Nakhon Pathom",
            "@id": "60012718",
            "affilname": "Mahidol University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60012718",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "Science Achievement Scholarship of Thailand",
        "Thailand Science Research and Innovation Fund Chulalongkorn University",
        "National Research council of Thailand",
        "KURDI"
    ]
}